Wells Fargo’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-81,599
| Closed | -$1.43M | – | 7742 |
|
|
2020
Q4 | $1.43M | Buy |
81,599
+2,994
| +4% | +$42K | ﹤0.01% | 3754 |
|
|
2020
Q3 | $919K | Sell |
78,605
-127,799
| -62% | -$1.7M | ﹤0.01% | 3931 |
|
|
2020
Q2 | $2.68M | Buy |
206,404
+84,988
| +70% | +$1.02M | ﹤0.01% | 3037 |
|
|
2020
Q1 | $1.12M | Buy |
121,416
+54,676
| +82% | +$764K | ﹤0.01% | 3475 |
|
|
2019
Q4 | $1.11M | Buy |
66,740
+26,305
| +65% | +$427K | ﹤0.01% | 3791 |
|
|
2019
Q3 | $673K | Buy |
40,435
+3,826
| +10% | +$52.9K | ﹤0.01% | 4157 |
|
|
2019
Q2 | $503K | Sell |
36,609
-11,837
| -24% | -$181K | ﹤0.01% | 4377 |
|
|
2019
Q1 | $834K | Buy |
48,446
+296
| +0.6% | +$4.68K | ﹤0.01% | 4018 |
|
|
2018
Q4 | $615K | Buy |
48,150
+2,330
| +5% | +$35.3K | ﹤0.01% | 4210 |
|
|
2018
Q3 | $744K | Buy |
45,820
+4,605
| +11% | +$65.8K | ﹤0.01% | 4164 |
|
|
2018
Q2 | $531K | Sell |
41,215
-431
| -1% | -$5.82K | ﹤0.01% | 4405 |
|
|
2018
Q1 | $518K | Sell |
41,646
-2,358
| -5% | -$28.7K | ﹤0.01% | 4359 |
|
|
2017
Q4 | $614K | Buy |
44,004
+5,284
| +14% | +$77.4K | ﹤0.01% | 4247 |
|
|
2017
Q3 | $651K | Buy |
38,720
+9,235
| +31% | +$150K | ﹤0.01% | 4152 |
|
|
2017
Q2 | $496K | Sell |
29,485
-36,452
| -55% | -$545K | ﹤0.01% | 4225 |
|
|
2017
Q1 | $1.02M | Buy |
65,937
+37,163
| +129% | +$531K | ﹤0.01% | 3734 |
|
|
2016
Q4 | $430K | Buy |
28,774
+7,579
| +36% | +$106K | ﹤0.01% | 4304 |
|
|
2016
Q3 | $266K | Buy |
21,195
+8,593
| +68% | +$86.3K | ﹤0.01% | 4315 |
|
|
2016
Q2 | $113K | Sell |
12,602
-2,613
| -17% | -$25.6K | ﹤0.01% | 4751 |
|
|
2016
Q1 | $150K | Buy |
15,215
+520
| +4% | +$5.33K | ﹤0.01% | 4586 |
|
|
2015
Q4 | $169K | Sell |
14,695
-213
| -1% | -$2.64K | ﹤0.01% | 4564 |
|
|
2015
Q3 | $201K | Buy |
14,908
+98
| +0.7% | +$1.33K | ﹤0.01% | 4470 |
|
|
2015
Q2 | $205K | Sell |
14,810
-351,895
| -96% | -$4.76M | ﹤0.01% | 4600 |
|
|
2015
Q1 | $5.16M | Sell |
366,705
-75,808
| -17% | -$1.03M | ﹤0.01% | 2351 |
|
|
2014
Q4 | $6.03M | Sell |
442,513
-1,685
| -0.4% | -$23K | ﹤0.01% | 2198 |
|
|
2014
Q3 | $6.78M | Buy |
444,198
+14,463
| +3% | +$222K | ﹤0.01% | 2061 |
|
|
2014
Q2 | $7.23M | Buy |
429,735
+183,798
| +75% | +$3.31M | ﹤0.01% | 2060 |
|
|
2014
Q1 | $4.94M | Buy |
245,937
+114,717
| +87% | +$2.48M | ﹤0.01% | 2331 |
|
|
2013
Q4 | $2.54M | Buy |
+131,220
| New | +$2.32M | ﹤0.01% | 2755 |
|
Wells Fargo's OXFD Position: Q1 2021 in Review
Wells Fargo sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 81,599 shares — an estimated $1.43M sold.
Wells Fargo first reported a position in OXFD in Q4 2013 and held it in 29 quarters. The position peaked at $7.23M in Q2 2014. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Wells Fargo reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Wells Fargo sold 81,599 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.43M.
- Wells Fargo first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 29 quarters.
- Wells Fargo's Oxford Immunotec Global PLC Ordinary Shares position peaked at $7.23M in Q2 2014.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.